Regenerative medicine: Transdifferentiation in vivo
A major challenge in regenerative medicine is the generation of functionally effective target cells to replace or repair damaged tissues.Transdifferentiation in vivo is a novel strategy to achieve cell fate conversion within the native physiological niche;this technology may provide a time-and cost-effective alternative for applications in regenerative medicine and may also minimize the concerns associated with in vitro culture and cell transplantation.
24
2014-03-20(万方平台首次上网日期,不代表论文的发表时间)
共2页
141-142